HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 183 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $278,873 | -17.5% | 8,510 | -11.4% | 0.17% | -15.5% |
| Q2 2023 | $338,141 | +97.3% | 9,609 | +83.1% | 0.20% | +112.8% |
| Q1 2023 | $171,347 | -39.7% | 5,248 | +1.7% | 0.09% | -36.5% |
| Q4 2022 | $284,261 | +21.0% | 5,159 | -2.6% | 0.15% | +57.4% |
| Q3 2022 | $235,000 | -7.5% | 5,296 | +1.5% | 0.09% | 0.0% |
| Q2 2022 | $254,000 | -46.1% | 5,218 | -46.1% | 0.09% | -55.5% |
| Q1 2022 | $471,000 | +14.0% | 9,686 | 0.0% | 0.21% | +35.3% |
| Q4 2021 | $413,000 | -24.6% | 9,686 | -32.2% | 0.16% | -35.3% |
| Q3 2021 | $548,000 | +24.5% | 14,291 | -8.4% | 0.24% | +33.1% |
| Q2 2021 | $440,000 | -13.0% | 15,603 | +1.8% | 0.18% | -15.4% |
| Q1 2021 | $506,000 | -6.1% | 15,322 | +2.8% | 0.21% | -4.5% |
| Q4 2020 | $539,000 | – | 14,899 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $618,113,619 | 97.50% |
| venBio Partners LLC | 1,035,396 | $57,050,320 | 17.69% |
| Vivo Capital, LLC | 2,606,247 | $143,604 | 16.53% |
| Nan Fung Group Holdings Ltd | 368,665 | $20,313,442 | 14.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $14,560,725 | 4.50% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 685,340 | $37,762,234 | 3.51% |
| ASHFORD CAPITAL MANAGEMENT INC | 356,638 | $19,650,754 | 3.05% |
| TANG CAPITAL MANAGEMENT LLC | 281,200 | $15,494,120 | 2.25% |
| MPM BioImpact LLC | 139,377 | $7,679,673 | 1.99% |
| O'Neil Global Advisors, Inc. | 7,335 | $404 | 1.86% |